Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Sinovac Biotech Ltd (SVA)

Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend Business Wire - Wed Jul 15, 1:00AM CDT

Sinovac Biotech Ltd. (NASDAQ: SVA) (“ SINOVAC ” or the “ Company ”), a leading provider of biopharmaceutical products in China, today announced that it has extended...

SVA : 6.47 (-0.31%)
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements Business Wire - Mon Jun 15, 5:00AM CDT

Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the...

SVA : 6.47 (-0.31%)
SINOVAC Reports Unaudited and Unreviewed Second Half of 2025 Financial Results and Files 2025 Annual Report on Form 20-F Business Wire - Fri Jun 5, 3:01PM CDT

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced it filed its annual report on Form 20-F for the fiscal...

SVA : 6.47 (-0.31%)
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report Business Wire - Fri May 29, 3:01PM CDT

Sinovac Biotech Ltd. (Nasdaq: SVA) (“ SINOVAC ” or the “ Company ”), a leading provider of biopharmaceutical products in China, today announced that it received a notification...

SVA : 6.47 (-0.31%)
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend Business Wire - Thu May 21, 5:30AM CDT

Sinovac Biotech Ltd. (NASDAQ: SVA) (“ SINOVAC ” or the “ Company ”), a leading provider of biopharmaceutical products in China, today announced that it has extended...

SVA : 6.47 (-0.31%)
SINOVAC Reports Unaudited First Half of 2025 Financial Results Business Wire - Fri May 8, 4:00PM CDT

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six months ended...

SVA : 6.47 (-0.31%)
SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024 Business Wire - Thu Apr 30, 8:22AM CDT

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the...

SVA : 6.47 (-0.31%)
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing Business Wire - Thu Jan 22, 5:00AM CST

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel (the “Panel”) has...

SVA : 6.47 (-0.31%)
SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement Business Wire - Sun Jan 4, 9:13AM CST

Sinovac Biotech Ltd. (NASDAQ: SVA) (“ SINOVAC ” or the “ Company ”), a leading provider of biopharmaceutical products in China, today provided an update on the Antigua...

SVA : 6.47 (-0.31%)
Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report Business Wire - Sun Jan 4, 9:00AM CST

Sinovac Biotech Ltd. (NASDAQ: SVA) (“ SINOVAC ” or the “ Company ”), a leading provider of biopharmaceutical products in China, today announced that it has received...

SVA : 6.47 (-0.31%)

Barchart Exclusives

This Dividend King Could Be One of the Safest Stocks to Own Right Now Barchart - Mon Jul 20, 6:30PM CDT
Abbott's diversified healthcare business is one of the main reasons why it remains a reliable dividend stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.